GII.4 Sydney_2012 norovirus infection in immunocompromised patients in Beijing and its rapid evolution in vivo

Journal of Medical Virology

Volumn 88, Issue 2, 2016, Pages 224-233

  Mai, Huan ^a   Gao, Yan ^a   Cong, Xu ^b   Wang, Hui ^b   Liu, Ning ^b   Huang, Xiaojun ^b   Xu, Lanping ^b   Chen, Yuhong ^b   Wei, Lai ^b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Diarrhea; Evolution; GII.4 Sydney_2012; Immunocompromised host; Norovirus

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLATE MOFETIL; TACROLIMUS; CAPSID PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASYMPTOMATIC INFECTION; CHINA; CHRONIC DIARRHEA; COLONOSCOPY; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GENE MUTATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; IMMUNOCOMPROMIZED PATIENT; IN VIVO STUDY; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR EVOLUTION; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; NOROVIRUS STRAIN GII.4 SYDNEY 2012; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CAPSID; VIRUS GENOME; VIRUS SHEDDING; YOUNG ADULT; AMINO ACID SUBSTITUTION; CALICIVIRIDAE INFECTIONS; CLASSIFICATION; DIARRHEA; DNA SEQUENCE; GENETICS; GENOTYPE; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MISSENSE MUTATION; MOLECULAR EPIDEMIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TERTIARY CARE CENTER; VIROLOGY;

ADOLESCENT; AGED; AMINO ACID SUBSTITUTION; BEIJING; CALICIVIRIDAE INFECTIONS; CAPSID PROTEINS; DIARRHEA; EVOLUTION, MOLECULAR; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MUTATION, MISSENSE; NOROVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TERTIARY CARE CENTERS; VIRUS SHEDDING; YOUNG ADULT;

EID: 84954376789     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24332     Document Type: Article

References (34)

1. Atmar RL. 2010. Noroviruses-state of the art. Food Environ Virol 2:117-126.
2. Bok K, Green KY. 2012. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 367:2126-2132.
3. Bull RA, Eden JS, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog 6:e1000831.
4. Cao S, Lou Z, Tan M, Chen Y, Liu Y, Zhang Z, Zhang XC, Jiang X, Li X, Rao Z. 2007. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 81:5949-5957.
5. Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinje J, Baric RS. 2013. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis 208:1877-1887.
6. Debbink K, Lindesmith LC, Ferris MT, Swanstom J, Beltramello M, Corti D, Lanzavecchia A, Baric RS. 2014. Within-host evolution results in antigenically distinct GII.4 noroviruses. J Virol 88:7244-7255.
7. Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN. 2012. Diagnosis and management of acute graft-versus-host disease. Br J Haematol 158:30-45.
8. Frange P, Touzot F, Debre M, Heritier S, Leruez-Ville M, Cros G, Rouzioux C, Blanche S, Fischer A, Avettand-Fenoel V. 2012. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. J Infect Dis 206:1269-1274.
9. Gao Y, Jin M, Cong X, Duan Z, Li H, Guo X, Zuo Y, Zhang Y, Zhang Y, Wei L. 2011. Clinical and molecular epidemiologic analyses of norovirus-associated sporadic gastroenteritis in adults from Beijing, China. J Med Virol 83:1078-1085.
10. Haessler S, Granowitz EV. 2013. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med 368:971.
11. Hall AJ, Wikswo ME, Manikonda K, Roberts VA, Yoder JS, Gould LH. 2013. Acute gastroenteritis surveillance through the National Outbreak Reporting System, United States. Emerg Infect Dis 19:1305-1309.
12. Hoffmann D, Hutzenthaler M, Seebach J, Panning M, Umgelter A, Menzel H, Protzer U, Metzler D. 2012. Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients. Infect Genet Evol 12:461-466.
13. Holbrook I. 2005. The British Society of Gastroenterology guidelines for the investigation of chronic diarrhoea, 2nd edition. Ann Clin Biochem 42:170-174.
14. Kaufman SS, Chatterjee NK, Fuschino ME, Magid MS, Gordon RE, Morse DL, Herold BC, LeLeiko NS, Tschernia A, Florman SS, Gondolesi GE, Fishbein TM. 2003. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant 3:764-768.
15. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, Baric RS. 2008. Mechanisms of G II.4 norovirus persistence in human populations. PLoS Med 5:e31.
16. Lindesmith LC, Donaldson EF, Baric RS. 2011. Norovirus GII.4 strain antigenic variation. J Virol 85:231-242.
17. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS. 2012. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog 8:e1002705.
18. Lindesmith LC, Costantini V, Swanstrom J, Debbink K, Donaldson EF, Vinje J, Baric RS. 2013. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol 87:2803-2813.
19. Lopman B, Zambon M, Brown DW. 2008. The evolution of norovirus, the "gastric flu". PLoS Med 5:e42.
20. Mai H, Jin M, Guo X, Liu J, Liu N, Cong X, Gao Y, Wei L. 2013. Clinical and epidemiologic characteristics of norovirus GII.4 Sydney during winter 2012-2013 in Beijing, China following Its global emergence. PLoS ONE 8:e71483.
21. Mai H, Gao Y, Pan X, Han J, Cong X, Wei L. 2014. [Study on norovirus GII.4/Sydney 2012 variant in China]. Zhonghua Liu Xing Bing Xue Za Zhi 35:157-162.
22. Mesquita JR, Barclay L, Nascimento MS, Vinje J. 2010. Novel norovirus in dogs with diarrhea. Emerg Infect Dis 16:980-982.
23. Munir N, Liu P, Gastanaduy P, Montes J, Shane A, Moe C. 2014. Norovirus infection in immunocompromised children and children with hospital-acquired acute gastroenteritis. J Med Virol 86:1203-1209.
24. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD. 2008. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 14:1224-1231.
25. Roddie C, Paul JP, Benjamin R, Gallimore CI, Xerry J, Gray JJ, Peggs KS, Morris EC, Thomson KJ, Ward KN. 2009. Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis 49:1061-1068.
26. Roos-Weil D, Ambert-Balay K, Lanternier F, Mamzer-Bruneel MF, Nochy D, Pothier P, Avettand-Fenoel V, Anglicheau D, Snanoudj R, Bererhi L, Thervet E, Lecuit M, Legendre C, Lortholary O, Zuber J. 2011. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 92:61-69.
27. Schorn R, Hohne M, Meerbach A, Bossart W, Wuthrich RP, Schreier E, Muller NJ, Fehr T. 2010. Chronic norovirus infection after kidney transplantation: Molecular evidence for immune-driven viral evolution. Clin Infect Dis 51:307-314.
28. Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt-Hieber M, Flegel WA, Thiel E, Schneider T. 2011. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 117:5850-5856.
29. Siebenga JJ, Beersma MF, Vennema H, van Biezen P, Hartwig NJ, Koopmans M. 2008. High prevalence of prolonged norovirus shedding and illness among hospitalized patients: A model for in vivo molecular evolution. J Infect Dis 198:994-1001.
30. Thongprachum A, Chan-It W, Khamrin P, Saparpakorn P, Okitsu S, Takanashi S, Mizuguchi M, Hayakawa S, Maneekarn N, Ushijima H. 2014. Molecular epidemiology of norovirus associated with gastroenteritis and emergence of norovirus GII.4 variant 2012 in Japanese pediatric patients. Infect Genet Evol 23:65-73.
31. Wingfield T, Gallimore CI, Xerry J, Gray JJ, Klapper P, Guiver M, Blanchard TJ. 2010. Chronic norovirus infection in an HIV-positive patient with persistent diarrhoea: A novel cause. J Clin Virol 49:219-222.
32. Yang Y, Xia M, Tan M, Huang P, Zhong W, Pang XL, Lee BE, Meller J, Wang T, Jiang X. 2010. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987-2008. J Virol 84:9595-9607.
33. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323.
34. van Beek J, Ambert-Balay K, Botteldoorn N, Eden J, Fonager J, Hewitt J, Iritani N, Kroneman A, Vennema H, Vinje J, White P, Koopmans M. 2013. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill 18:8-9.